Home/Filings/4/0001437749-16-033574
4//SEC Filing

NovaBay Pharmaceuticals, Inc. 4

Accession 0001437749-16-033574

$NBYCIK 0001389545operating

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 11:35 AM ET

Size

5.0 KB

Accession

0001437749-16-033574

Insider Transaction Report

Form 4
Period: 2016-06-06
Hall Justin
General Counsel
Transactions
  • Award

    stock option (right to buy)

    2016-06-06+130,000135,160 total
    Exercise: $2.78From: 2017-01-31Exp: 2026-06-06Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]All of the shares will vest on January 31, 2017, in direct proportion to the percentage achievement of the stated 2016 corporate goals, as approved and determined by the Board.

Documents

1 file

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001389545

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 11:35 AM ET
Size
5.0 KB